Related Experiment Video

Updated: Jul 15, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway

Hasan M Kamrul1, Renu Wadhwa, Sunil C Kaul

  • 1Research Institute for Cell Engineering, National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8562, Japan.

Annals of the New York Academy of Sciences
|April 27, 2007
PubMed

Insights

CARF, a novel ARF collaborator, enhances p53 function independently or with ARF. CARF interacts with HDM2, leading to its degradation and influencing the p53-HDM2-p21(WAF1) pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The INK4a locus encodes tumor suppressors p16(INK4a) and ARF, crucial for cell cycle control and senescence.
  • ARF (alternative reading frame protein) plays a key role in tumor suppression.

Purpose of the Study:

  • To identify and characterize novel ARF-interacting proteins.
  • To elucidate the role of CARF in p53 regulation and cellular pathways.

Main Methods:

  • Two-hybrid interactive screen using mouse p19(ARF) as bait.
  • Co-immunoprecipitation and cellular localization studies.
  • Investigation of protein-protein interactions and degradation pathways.

Main Results:

  • CARF was identified as a novel ARF-interacting protein.
  • CARF interacts with ARF in the perinucleolar region and activates p53 function.
  • CARF directly interacts with p53, enhancing its function independently of ARF.
  • CARF interacts with HDM2 and is degraded via an HDM2-dependent proteasome pathway.
  • CARF influences the p53-HDM2-p21(WAF1) pathway.

Conclusions:

  • CARF is a crucial regulator of the p53 pathway, impacting cell cycle control, senescence, and DNA damage response.
  • CARF's interaction with HDM2 and subsequent degradation highlight a novel feedback mechanism.
  • CARF's multifaceted role suggests its importance in human cellular processes and potentially cancer.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...